Expand 701 drug price negotiation with volume and centralized purchase mode

The scope of purchase with volume may be expanded, and a batch of drugs will be negotiated Recently, Shanghai Sunshine purchase network released "work tips on" restricting pharmacy drugs to be put on the Internet for open price negotiation "and other related matters (2)", and 701 drugs began to be negotiated (see the end of the article for the catalog) Shanghai said that the retail price of all drugs sold in designated pharmacies (medical insurance counters) for medical insurance should be negotiated by designated pharmacies and drug manufacturers The negotiated price of designated pharmacies for medical insurance and drug manufacturers should be made public on the sunshine platform The negotiated price is only effective for the designated pharmacies The negotiated retail price should be consistent with the settlement price of medical insurance On June 26, Shanghai issued the working tips on "restricting drug stores to put drugs on the Internet for open price negotiation" and other related matters (1) According to the document, the manufacturer selects the drugs that are in use by the enterprise and are within the scope of "limited drugstore drugs are fully on the Internet for public price negotiation", fills in the purchase price and price certification pictures of 15 provinces and cities, and checks the specification, packaging and packaging units of the drugs The so-called "purchase price of other provinces and cities" is the "purchase price of 15 provinces and cities" Shanghai clearly refers to the purchase price that the same enterprise and the same variety are implementing on the provincial drug purchase platforms of Beijing, Tianjin, Jiangsu, Zhejiang, Guangdong, Chongqing, Anhui, Fujian, Jiangxi, Shandong, Henan, Hebei, Liaoning, Hubei and Hunan According to the judgment of two documents before and after Shanghai, one kind of analysis thinks that the medical insurance payment price of the same kind of drugs, the designated drugstores of medical insurance and hospitals are the same, which is helpful to accelerate the outflow of prescriptions From this dimension, there is certain inevitability, because the same kind of drugs have the same price inside and outside the hospital, it is likely to lead to patients actively choose hospital purchased drugs instead of going to the hospital to queue up and register On October 24, Zhejiang Medical Insurance Bureau issued the Interim Measures for the administration of designated pharmacies of basic medical insurance of Zhejiang Province (Draft for comments) It is clear that, in addition to the regulations on venue and certificate, the online trading drug varieties of Zhejiang medical equipment purchasing platform that need to be equipped should not be less than 50%, that is to say, at least half of the drugs in the pharmacies are the same as those in hospitals Shanghai's plan has a similar effect to the Zhejiang health insurance bureau's regulation on the stimulation of prescription outflow In fact, for the purpose of "restricting drugstores and drugs to be sold on the Internet in an all-round way" in Shanghai, according to cypress blue analysis, it is still necessary to avoid price depression and close the price loophole As we all know, at present, the price of some drugs sold by drugstores under the same general name is higher than that of hospitals, especially under the current mode of carrying quantity purchase, some drugs are greatly reduced in hospitals, which reduces the burden of patients and the waste of medical insurance funds However, the retail price of drugs sold by drugstores is higher than that of hospitals by changing the specifications and packaging It can be seen that in Shanghai, some drugstores are engaged in online drug price negotiation, which stipulates that the agreed retail price should be consistent with the settlement price of medical insurance The purpose is to sort out the drug price based on the payment price of medical insurance According to the statistics of mienei.com, the sales volume of drug terminals in China increased year by year from 2011 to 2018 In 2018, the sales volume of drugs in three major terminals and six major markets in China reached RMB 1713.1 billion, an increase of 7.3% year on year In 2018, the terminal drug sales of retail pharmacies in China reached 391.9 billion yuan, up 7.5% year on year If the retail price of some drugs in the retail terminal drops, it may affect the growth rate of the whole market.